Purpose Cisplatin-induced hearing loss (CIHL) is a common late effect after childhood
cancer treatment having profound, lifelong consequences that lower quality of life. The …

Purpose To elucidate the long-term impacts of hearing loss, tinnitus and balance in people
living with and beyond cancer (LWBC) treated with platinum-based chemotherapy (PBCT) …

Background Increasing attention has been dedicated to investigate modifiable risk factors of
late effects in survivors of childhood cancer. This study aims to evaluate neurocognitive and …

Purpose The Pediatric Normal Tissue Effects in the Clinic (PENTEC) hearing loss (HL) task
force reviewed investigations on cochlear radiation dose-response relationships and risk …

A new era of treatment for childhood cancer has welcomed an increasing number of long-
term survivors, for whom acute and late neurologic and neurocognitive sequelae related to …

Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it
Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it Pediatr …

Purpose Little is known regarding long-term neurocognitive outcomes in osteosarcoma and
Ewing sarcoma (EWS) survivors despite potential risk factors. We evaluated associations …

PURPOSE Hearing loss (HL) is a serious secondary effect of treatment for CNS and head-
and-neck tumors in children. The goal of this study was to evaluate incidence and risk …

Simple Summary Medulloblastoma is the most common malignant central nervous system
tumor in the pediatric population. Treatment modalities are stratified by age, extent of …

Background Hearing loss is a potential side effect from childhood cancer treatment. We
described the severity of hearing loss assessed by audiometry in a representative national …